A ganglioglioma is a rare, slow-growing brain tumor that contains both nerve cells and glial cells. It is most often diagnosed in children and young adults, and it frequently causes seizures. While the word “tumor” sounds alarming, most gangliogliomas are low-grade, meaning they grow slowly and have a good outlook after treatment.
What Exactly Is a Ganglioglioma?
A ganglioglioma is a mixed tumor. It is made up of two different cell types: mature neurons (ganglion cells) and glial cells, which normally support and protect nerve cells. This combination is unusual because mature neurons rarely divide. That is one reason these tumors tend to grow so slowly.
Most gangliogliomas are classified as Grade I or Grade II tumors by the World Health Organization. Grade I tumors are benign and slow-growing. Grade II tumors are also slow-growing but have slightly more atypical features. High-grade gangliogliomas (Grade III or IV) are extremely rare and behave much more aggressively.
These tumors can appear anywhere in the brain or spinal cord. However, they have a strong preference for the temporal lobe, which is the part of the brain that processes hearing, language, and memory. This location explains why seizures are such a common first symptom.
What Are the Symptoms of a Ganglioglioma?
The most common symptom is seizures. Studies consistently show that 70% to 90% of people with a ganglioglioma experience seizures before diagnosis. Many of these seizures are drug-resistant, meaning standard anti-seizure medications do not control them well.
Other symptoms depend entirely on where the tumor sits. A tumor in the temporal lobe might cause memory problems, confusion, or odd sensory experiences. A tumor pressing on the optic nerve can affect vision. A tumor in the spinal cord can cause weakness, numbness, or trouble walking.
General symptoms of increased pressure inside the skull can also occur. These include:
- Headaches, especially ones that are worse in the morning
- Nausea or vomiting without a clear cause
- Balance problems
- Changes in personality or behavior
Because these tumors grow so slowly, symptoms often develop gradually over months or even years. A person might have a single seizure and get diagnosed quickly. Or someone might have vague symptoms for a long time before imaging reveals the cause.
How Is a Ganglioglioma Diagnosed?
Diagnosis usually begins with a neurological exam and a review of symptoms. If a tumor is suspected, the next step is imaging. An MRI is the standard test. Gangliogliomas have a fairly characteristic appearance on MRI — often a well-defined mass with a cyst-like component. But imaging alone cannot confirm the diagnosis with certainty.
A biopsy or surgical removal is required for a definitive diagnosis. A neuropathologist examines the tissue under a microscope. The presence of both dysplastic ganglion cells and glial cells confirms the diagnosis. Molecular testing is increasingly used to look for specific genetic changes, particularly the BRAF V600E mutation. This mutation is found in roughly 20% to 60% of gangliogliomas, depending on the study.
An electroencephalogram (EEG) is often performed if the patient has seizures. The EEG helps identify where the seizure activity originates. This information is useful because surgery to remove the tumor often also cures the seizures.
What Are the Treatment Options?
Surgery is the primary treatment for gangliogliomas. The goal is complete surgical removal, called a gross-total resection. When the entire tumor is removed, the prognosis is excellent. Many patients are cured with surgery alone, and their seizures often stop completely.
Complete removal is not always possible. This can happen if the tumor is located near critical brain areas that control speech, movement, or vision. In those cases, the surgeon may remove as much as safely possible, which is called a subtotal resection.
For residual tumor after surgery, or for high-grade tumors, additional treatment may be recommended. Radiation therapy is sometimes used, though it carries risks — especially in children, where it can affect cognitive development. Chemotherapy is generally reserved for tumors that recur or that do not respond to other treatments.
Some low-grade gangliogliomas are watched with regular MRI scans rather than treated immediately, particularly if surgery carries high risk. This approach is called watchful waiting or active surveillance. It is a reasonable option because these tumors grow so slowly.
What Is the Prognosis and Long-Term Outlook?
For low-grade gangliogliomas that are completely removed, the outlook is very good. The recurrence rate after gross-total resection is low. Most patients survive long-term, and many are cured.
The prognosis is less favorable when the tumor cannot be fully removed or when it is high-grade. Incomplete resection is associated with a higher chance of recurrence. High-grade gangliogliomas are aggressive and require more intensive treatment.
Seizure outcomes are worth noting separately. When the tumor is fully removed, seizure control improves dramatically. Studies have found that a large majority of patients become seizure-free after surgery. For patients whose seizures persist, anti-seizure medications may still be needed.
Long-term follow-up is standard practice. Even after successful treatment, patients typically have regular MRI scans for several years to monitor for recurrence.
Are There Any Risk Factors or Causes?
No clear environmental risk factors have been identified for gangliogliomas. They are not linked to head trauma, cell phone use, or any specific lifestyle factor. There is no evidence that they are caused by anything a person did or did not do.
The BRAF V600E mutation is the most commonly identified genetic change in these tumors. This mutation is not inherited — it arises spontaneously in the tumor tissue. It is not passed down through families.
Some rare genetic conditions, such as neurofibromatosis type 1, are associated with a higher risk of certain brain tumors. However, gangliogliomas are not strongly linked to these syndromes in most cases.
Frequently Asked Questions
Is a ganglioglioma cancer?
Most gangliogliomas are low-grade tumors, not cancer in the aggressive sense. High-grade gangliogliomas exist but are extremely rare and behave much more like cancer.
Can a ganglioglioma be cured?
Yes, when the tumor is completely removed with surgery, the cure rate is high. Incomplete removal leaves a higher chance of recurrence.
Do seizures go away after ganglioglioma surgery?
Many patients become seizure-free after complete tumor removal. Seizure outcomes are generally better with gross-total resection than with partial removal.
What is the survival rate for ganglioglioma?
Survival rates are very high for low-grade tumors that are fully resected. Rates drop for high-grade tumors, but these are rare and account for a small fraction of cases.
A ganglioglioma diagnosis is serious, but the word “tumor” does not automatically mean a poor outcome. Most people with these tumors have low-grade disease that responds well to surgery. Seizures — often the first sign — frequently resolve after treatment. If you or a loved one has been diagnosed, the most important step is a thorough discussion with a neurosurgeon and neuro-oncologist about the specific tumor type, location, and treatment plan.
